Evidence map›Paper›PMID 41477565›Full record

ArticleEClinicalMedicine2025

Artifical intelligence-powered delta-NIHSS-based model for predicting recurrence, disability and mortality after acute ischaemic strokes (DISCO): a modelling study.

Shiyao Cheng, Yuandan Wei, Huaguang Zheng, Qingrong Zhang, Xuanyan Yang, Zhen Lu, Zehua Huang, Zijun Wan, Yanfeng Shi, Jie Zhang and 18 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Shiyao ChengChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Yuandan WeiSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Huaguang ZhengChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Qingrong ZhangSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Xuanyan YangSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Zhen LuSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Zehua HuangSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Zijun WanSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.
Yanfeng ShiChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Jie ZhangChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Jay Chol ChoiDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju city, Republic of Korea.
Chul-Hoo KangDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju city, Republic of Korea.
Hong Jun KimDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju city, Republic of Korea.
Joong-Goo KimDepartment of Neurology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju city, Republic of Korea.
Hee-Joon BaeDepartment of Neurology, Seoul National University College of Medicine, Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Seongnam, South Korea.
Juneyoung LeeDepartment of Biostatistics, Korea University, College of Medicine, Seoul, South Korea.
Jeong-Yoon LeeDepartment of Neurology, Soonchunhyang University, Seoul Hospital, Seoul, South Korea.
Hannah JungDepartment of Biostatistics, Korea University, College of Medicine, Seoul, South Korea.
Cang GuoChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xiaoling LiaoChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Jianping WuChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xia MengChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zixiao LiChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Stéphanie DebetteParis Brain Institute (ICM), Sorbonne Université, Paris, France.
Hao LiChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Yongjun WangChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Si ChengChina National Clinical Research Center for Neurological Diseases, and the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Siyang LiuSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Stroke is a leading cause of mortality and disability globally, with high rates of adverse outcomes. We aimed to develop and test a clinically accessible and explainable predictive model for post-stroke composite outcomes that could identify patients at high-risk for targeted interventions. Methods: This modelling study used artificial intelligence to develop and validate a prognostic predictive model for post-stroke outcomes at 3 months and over 5 years, using comprehensive data from the third China National Stroke Registry (CNSR-III; 2015-2018). The development cohort comprised 11,313 patients from CNSR-III. Validation cohort 1 (n = 2627 from CNSR-III; internal validation) were selected at random on the basis of hospital assignment. Validation cohort 2 (external validation) included 5158 patients with a history of ischaemic stroke, excluding those diagnosed with TIA, from the CHANCE-2 trial (2019-2021) done at 202 centres in China. Validation cohort 3 (external validation: disability and mortality) involved 3855 patients with a history of acute ischaemic stroke or TIA from a single centre in the Clinical Research Center for Stroke-Fifth Division (CRCS-5) cohort (2011-2024) in South Korea. We evaluated 309 hospitalisation variables, including baseline characteristics, medical history, hospitalisation data, biomarkers, geographical factors, National Institutes of Health Stroke Scale (NIHSS) scores, modified Rankin Scale (mRS), and stroke polygenic risk scores, using an extreme gradient boosting tree model. Feature importance was assessed via Shapley values. Primary outcomes were 3-month stroke recurrence, disability (mRS >2), and mortality. Secondary outcomes were assessed at six additional time points over 5 years. A nested cross-validation scheme was employed for feature selection and internal validation in 80% of patients (n = 11,313) from CNSR-III cohort. Testing was performed in the remaining 20% of patients (n = 2627) from CNSR-III (validation cohort 1). External validation was performed in validation cohorts 2 and 3. Findings: Global and domain-specific delta-NIHSS Interpretation: The DISCO model, incorporating 23 clinical variables, demonstrates high accuracy, robustness, clinical accessibility, and explainability in predicting post-stroke outcomes. The predictive strength of delta-NIHSS Funding: National Key Research and Development Program of China, National Natural Science Foundation of China, Young Elite Scientists Sponsorship Program by the China Association for Science and Technology, and Young Talents Supporting Program of Capital Medical University.

Indexed as

Delta-NIHSSExplainable machine learningIschaemic stroke outcomesPrognostic predictive model

Identifiers

PMID41477565
PMCPMC12753274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.